Enhancement of the efficacy of cancer chemotherapy by the pineal hormone melatonin and its relation with the psychospiritual status of cancer patients

Journal of Research in Medical Sciences

Volumn 15, Issue 4, 2010, Pages

  Messina, Giuseppina ^a   Lissoni, Paolo ^b   Marchiori, Paolo ^c   Bartolacelli, Erio ^d   Brivio, Fernando ^d   Magotti, Luciano ^e  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b Institute of Biological Medicine   (Italy)

^c Natur Spiritual   (Italy)

^d Bassini Hospital   (Italy)

^e Foundation Legrenzi Cazzullo   (Italy)

Author keywords

Bioimmunomodulation; Chemotherapy; Lung cancer; Melatonin; Psychoncology; Spirituality

Indexed keywords

CISPLATIN; GEMCITABINE; MELATONIN;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENTIATION; EVENING DOSAGE; FEMALE; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; MALE; MULTIPLE CYCLE TREATMENT; PSYCHOLOGIC ASSESSMENT; RELIGION; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR REGRESSION;

EID: 77954771408     PISSN: 17351995     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Herberman RB. Design of clinical trials with biological response modifiers. Cancer Treat Rep 1985;69(10):1161-4.
2. Foon KA. Biological response modifiers: the new immunotherapy. Cancer Res 1989;49(7):1621-39.
3. Cameron D. Bevacizumab in the first-line treatment of metastatic breast cancer. Eur J Cancer Supplements 2008;6(6):21-8.
4. Escudier B, Cosaert J, Jethwa S. Targeted therapies in the management of renal cell carcinoma: role of bevacizumab. Biologics 2008;2(3):517-30.
5. Chinery R, Brockman JA, Peeler MO, Shyr Y, Beauchamp RD, Coffey RJ. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colotrectl cancer: a p53-independent induction of p12WAF1/CIP1 via C/EBPbeta. Nat Med 1997;3(11):1233-41.
6. Brzezinski A. Melatonin in humans. N Engl J Med 1997;336(3):186-95.
7. Regelson W, Pierpaoli W. Melatonin: a rediscovered antitumor hormone? Its relation to surface receptors; sex steroid metabolism, immunologic response, and chronobiologic factors in tumor growth and therapy. Cancer Invest 1987;5(4):379-85.
8. Maestroni GJM. The immunoneuroendocrine role of melatonin. J Pineal Res 1993;14(1):1-10.
9. Sze SF, Ng TB, Liu WK. Antiproliferative effect of pineal indoles on cultured tumor cell lines. J Pineal Res 1993;14(1):27-33.
10. Lissoni P. Is there a role for melatonin in supportive care? Support Care Cancer 2002;10(2):110-6.
11. Vogler BK, Ernst E. Aloe Vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999;49(447):823-8.
12. Lissoni P, Messina G, Balestra A, Colciago M, Brivio F, Fumagalli L, et al. Efficacy of cancer chemotherapy in relation to synchronization of cortisol rhythm, immune status and psychospiritual profile in metastatic non-small cell lung cancer. In Vivo 2008;22(2):257-62.
13. Rubinow DR. Brain, behavior and immunity: an interactive system. J Natl Cancer Inst Monogr 1990;(10):79-82.
14. Jankovic BD. Neuroimmunomodulation. From phenomenology to molecular evidence. Ann NY Acad Sci 1994;741:1-38.
15. Ursin H. The psychology in Psychoneuroendocrinology. Psychoneuroendocrinology 1998;23(6):555-70.
16. Lissoni P, Messina G, Parolini D, Balestra A, Brivio F, Fumagalli L, et al. A Spiritual approach in the treatment of cancer: relation between faith score and response to chemotherapy in advanced non-small cell lung cancer patients. In Vivo 2008;22(5):577-81.